Agenus
AGEN
#8980
Rank
NZ$0.23 B
Marketcap
NZ$6.82
Share price
4.27%
Change (1 day)
21.64%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): NZ$35.28 Million

According to Agenus 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2024 the company made an earning of -NZ$0.2 Billion, an increase over its 2023 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$35.28 M-117.65%
2024 -NZ$0.2 Billion-28.13%
2023 -NZ$0.28 Billion-5.5%
2022 -NZ$0.3 Billion-556.26%
2021 NZ$64.52 M-130.37%
2020 -NZ$0.22 Billion73.75%
2019 -NZ$0.13 Billion-48.74%
2018 -NZ$0.24 Billion34.32%
2017 -NZ$0.18 Billion-7.16%
2016 -NZ$0.2 Billion26.55%
2015 -NZ$0.16 Billion110.24%
2014 -NZ$71.91 Million49.12%
2013 -NZ$48.22 Million
2011 -NZ$33.3 Million-12.25%
2010 -NZ$37.95 Million-21.41%
2009 -NZ$48.28 Million-26.86%
2008 -NZ$66.01 Million13.72%
2007 -NZ$58.05 Million-33.4%
2006 -NZ$87.16 Million-31.84%
2005 -NZ$0.13 Billion9.74%
2004 -NZ$0.12 Billion-0.8%
2003 -NZ$0.12 Billion17.37%
2002 -NZ$0.11 Billion37.83%
2001 -NZ$72.61 Million55.99%
2000 -NZ$46.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
NZ$40.27 B 111,645.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.26 B 45,018.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$56.50 B 156,682.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.45 Billion-1,340.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$14.01 B 38,776.25%๐Ÿ‡บ๐Ÿ‡ธ USA